Enrico has been Head of Rare Diseases EU & RoW at the Chiesi Group since November 2019, leading a team promoting and commercializing treatments for rare and ultra-rare diseases.
He previously had a long tenure in Genzyme and SanofiGenzyme covering since 2002 different sub-regional and regional/EMEA/EU roles in both functional areas and business ones.
During the last 7 years as General Manager of SanofiGenzyme Italy & Malta he led his team through different launches and sustained business growth within Rare and other Specialty Care diseases.
Since 2010 he is part of the EMEA and European Management team.
He is member of various Biotech/RD and Orphan Drugs groups and associations where he plays an active role.
Previously, Enrico held functional directorship roles at local/Italy or regional/EU level within Industrial Operations and Commercial ones in different contexts.
After a post-degree period in US, in 1995 he started his career in Italy at Arthur Anderssen consulting.
He was trained at the Organization&Processes Master at the Bocconi University in Milan and he previously obtained his University Degree in Business Administration at Modena University.